FP
Flagship Pioneering Portfolio holdings
AUM
$268M
This Quarter Return
+94.34%
1 Year Return
-54.4%
3 Year Return
-51.2%
5 Year Return
+66.7%
10 Year Return
–
AUM
$3.44B
AUM Growth
+$3.44B
(+61%)
Cap. Flow
-$648M
Cap. Flow
% of AUM
-18.82%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
3
Reduced
1
Closed
–
Top Buys
| 1 |
EVLO
Evelo Biosciences, Inc. Common Stock
EVLO
|
$22.9M |
| 2 |
AXLA
Axcella Health Inc. Common Stock
AXLA
|
$21M |
| 3 |
KLDO
Kaleido Biosciences, Inc. Common Stock
KLDO
|
$14.9M |
Top Sells
| 1 |
Moderna
MRNA
|
$706M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Moderna
MRNA
$9.37B
| $2.56B | 74.39% | 39,871,524 -11,000,000 | -22% | -$706M |
|
|
RUBY
2
DELISTED
Rubius Therapeutics, Inc
RUBY
| $229M | 6.65% | 38,296,526 | – | – |
|
3
Denali Therapeutics
DNLI
$2.23B
| $193M | 5.61% | 7,980,263 | – | – |
|
|
KLDO
4
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
| $144M | 4.18% | 19,360,710 +2,000,000 | +12% | +$14.9M |
|
|
EVLO
5
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
| $112M | 3.26% | 22,900,069 +4,666,666 | +26% | +$22.9M |
|
6
Seres Therapeutics
MCRB
$166M
| $103M | 2.98% | 21,571,764 | – | – |
|
|
AXLA
7
DELISTED
Axcella Health Inc. Common Stock
AXLA
| $69.4M | 2.02% | 12,548,414 +3,800,000 | +43% | +$21M |
|
|
SYRS
8
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $31.3M | 0.91% | 2,938,494 | – | – |
|